Lista de obras -

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

artículo científico publicado en 2016

Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR-/- Mice

scientific article published on 24 October 2019

Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys

artículo científico publicado en 2017

Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys

artículo científico publicado en 2014

Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection

artículo científico publicado en 2011

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function

artículo científico publicado en 2016

Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions

artículo científico publicado en 2011

Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors

artículo científico publicado en 2012

An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice

artículo científico publicado en 2013

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

artículo científico publicado en 2018

Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus

artículo científico publicado en 2016

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization

artículo científico publicado en 2015

Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens

artículo científico publicado en 2014

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)

artículo científico publicado en 2020

Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors

artículo científico publicado en 2014

Differential Outcomes Following Optimization of Simian-Human Immunodeficiency Viruses From Clades AE, B and C

artículo científico publicado en 2020

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

artículo científico publicado en 2017

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

artículo científico publicado en 2018

Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys

artículo científico publicado en 2018

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

artículo científico publicado en 2018

Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains

artículo científico publicado en 2012

Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors

artículo científico publicado en 2014

Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

scientific article published on 22 July 2016

Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaques

artículo científico publicado en 2019

Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses

artículo científico publicado en 2014

Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.

artículo científico publicado en 2016

Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation

artículo científico publicado en 2020

Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques

scientific article published on 01 October 2020

Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.

artículo científico publicado en 2017

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys ⬇️

scientific article published on 24 October 2013

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

artículo científico publicado en 2015

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

artículo científico publicado en 2016

Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

artículo científico publicado en 2018

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors

artículo científico publicado en 2018

Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys

artículo científico publicado en 2016

Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

artículo científico publicado en 2014

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

artículo científico publicado en 2022

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

artículo científico publicado en 2020

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

artículo científico publicado en 2021

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys

artículo científico publicado en 2018

Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika-specific antibodies

scientific article published on 17 June 2020

Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys.

artículo científico publicado en 2018

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques

artículo científico publicado en 2022

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

artículo científico publicado en 2013

Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses

artículo científico publicado en 2016

Vaccine protection against Zika virus from Brazil

artículo científico publicado en 2016

Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection

artículo científico publicado en 2015

Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys

artículo científico publicado en 2017

Lista de obras de

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR-/- Mice

Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys

Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys

Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function

Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions

Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors

An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization

Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)

Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors

Differential Outcomes Following Optimization of Simian-Human Immunodeficiency Viruses From Clades AE, B and C

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains

Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors

Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaques

Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses

Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.

Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation

Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques

Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys ⬇️

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors

Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys

Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys

Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika-specific antibodies

Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys.

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses

Vaccine protection against Zika virus from Brazil

Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection

Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys